LBA38 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: A randomized, double-blind, phase III ENGOT-cx11/GOG-3047/KEYNOTE-A18 study

Domenica Lorusso, Y. Xiang, K. Hasegawa, Giovanni Scambia, M.H. Leiva Gálvez, Pierre Elias, Andrés Acevedo, Júlia Vízkeleti, A.J.P.D.S. Gomes, Fernando Contreras Mejía, Allison B. Reiss, Asude Ayhan, J-Y. Lee, В. В. Саевец, Flora Zagouri, Ka Wan Li, K.U. Yamada, S. Toker, Sandro Pignata, Linda Duska